|
|
Volumn 106, Issue 6 SUPPL., 1994, Pages 399S-407S
|
|
Future directions in clinical research for lung cancer
a
a
Box B188
*
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CALCIUM;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
EDATREXATE;
ETOPOSIDE;
FLAVONOID;
FLUOROURACIL;
GEMCITABINE;
IFOSFAMIDE;
IRINOTECAN;
MITOMYCIN;
NAVELBINE;
PACLITAXEL;
RETINOL;
TOPOTECAN;
VINDESINE;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER PREVENTION;
CANCER RESEARCH;
CANCER SCREENING;
CANCER SURGERY;
CLINICAL RESEARCH;
CLINICAL TRIAL;
EARLY DIAGNOSIS;
HUMAN;
LUNG CANCER;
PRIORITY JOURNAL;
|
|
EID: 0027949296
PISSN: 00123692
EISSN: None
Source Type: Journal
DOI: 10.1378/chest.106.6_Supplement.399S Document Type: Article |
|
Times cited : (13)
|
|
References (0)
|
